An expert in the management of skin conditions reviews the management of atopic dermatitis with a special emphasis on hand and foot involvement. She shares her expertise by reviewing real-world scenarios and practical strategies for optimizing patient care in these challenging areas.
EP. 2: Barrier Function and Atopic Dermatitis
March 29th 2024A dermatology expert reviews the role of barrier function in AD and outlines available treatments, emphasizing the importance of moisturizing and rapid options when appropriate, as well as the efficacy of rapid systemic treatments in patients when appropriate.
EP. 3: Disease Severity's Influence on Atopic Dermatitis Therapeutic Selection
April 5th 2024Dr. Golant discusses the role of disease severity in her selection of atopic dermatitis treatments, particularly noting the characterization of hand and foot involved patients as often moderate cases, and highlighting the rapid response observed in these areas when treated.
EP. 4: The AD Journey of a Construction Worker: Insights from a 38-Year-Old Caucasian Male
April 5th 2024Alexandra Golant, MD, presents the case of a 38-year-old Caucasian male construction worker, diagnosed with moderate AD at age 15, and his treatment history with various interventions and physician referral considerations.
EP. 5: Empowering Patients: Effective Dermatologic Treatment Selection for Hand and Feet AD
April 12th 2024Dr Golant continues with the case of the 38-year old patient with atopic dermatitis and explore effective strategies for navigating treatment selection and planning in this condition, focusing on discussing options with patients and instilling confidence in the chosen approach.
EP. 6: Understanding Drug Interactions in Systemic Treatment: Impact on Atopic Dermatitis Symptoms
April 12th 2024Dr Alexandra Golant discusses managing multiple conditions in a 17-year-old African American waitress, highlighting the complexities of treating moderate-to-severe atopic dermatitis alongside severe acne and oral contraceptives. She also addresses potential drug interactions, focusing on the safety of dupilumab in systemic treatment.